[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367879-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367879-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tp53-gene-and-pathway-alterations-in-gastric-type-adenocarcinoma-of-the-cervix","TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix","","Background: Human papillomavirus infection underlies almost all cervical malignancies, except gastric-type adenocarcinoma of the cervix, a rare aggressive subtype without human papillomavirus infection. Methods: Comparative multi-omics analysis contrasted gastric-type adenocarcinoma and usual-type endocervical adenocarcinoma across three independent cohorts using targeted/whole transcriptome sequencing and public mutational resources; metabolomics was included in a subset. Results: TP53 mutations were consistently more prevalent, with frequent suppression of TP53-related pathways and metabolites suggesting TP53-driven intratumoral metabolic properties. Conclusion: Gastric-type disease development is likely driven by TP53 mutations shaping tumor signaling and metabolism.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tp53-gene-and-pathway-alterations-in-gastric-type-adenocarcinoma-of-the-cervix/367879/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tp53-gene-and-pathway-alterations-in-gastric-type-adenocarcinoma-of-the-cervix/367879.png","ImageObject",300,407,{"name":42,"@type":43},"Mary Man","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is TP53 a focus in gastric-type adenocarcinoma of the cervix?","Question",{"text":63,"@type":64},"The study targets carcinogenic mechanisms in a rare HPV-independent subtype, finding TP53 mutations more common in gastric-type tumors than in usual-type endocervical adenocarcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the multi-omics datasets organized in the study?",{"text":68,"@type":64},"Comparisons were performed across three independent cohorts, combining targeted and whole transcriptome sequencing for one cohort and mutational data from public genomic databases for additional cohorts.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular pathway and metabolite findings support the role of TP53?",{"text":72,"@type":64},"Transcriptome analysis showed frequent suppression of TP53-related pathways, and metabolite patterns in gastric-type tissues indicate TP53 alterations contribute to intratumoral metabolic properties.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367879,1790390195,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","JNCI Cancer Spectrum, 2025, 9(5), pkaf082  \n[https://doi.org/10.1093/jncics/pkaf082](https://doi.org/10.1093/jncics/pkaf082)  \nAdvance Access Publication Date: August 11, 2025  \nArticle  \nTP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix  \nDaiki Higuchi, MD1, 2, Maiko Yamaguchi, MD1,3, Erisa Fujii , MD1,4, Mayumi Kobayashi Kato , MD, PhD1,4, Kengo Hiranuma, MD, PhD3, Yuka Asami , MD, PhD1, 2, Hanako Ono, PhD5, Takafumi Koyama , MD, PhD6,  \nMasaaki Komatsu , MD, PhD7,8, Ryuji Hamamoto , PhD7,8, Yasuhisa Terao , MD, PhD3, Koji Matsumoto , MD, PhD2, Akihiko Sekizawa , MD, PhD2, Mitsuya Ishikawa , MD, PhD4, Takashi Kohno , PhD1, Hiroshi Yoshida , MD, PhD9, Hideki Makinoshima , PhD10, Kouya Shiraishi , PhD1, 5, 􀀃 , Tomoyasu Kato , MD, PhD4  \n1Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan 2Department of Obstetrics and Gynecology, Showa Medical University, Tokyo, Japan 3Department of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan 4Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan  \n5Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan 6Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan  \n7Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan 8Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan 9Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan  \n10Tsuruoka Metabolomics Laboratory, National Cancer Center Tsuruoka, Yamagata, Japan  \n􀀃 Corresponding author: Kouya Shiraishi, PhD, Division of Genome Biology, National Cancer Center Research Institute; Department of Clinical Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan ([kshirais@ncc.go.jp](kshirais@ncc.go.jp)) .  \nAuthor Contribution: Tomoyasu Kato contributed equally as senior authors.  \nAbstract  \nBackground: Human papillomavirus infection contributes to the development of almost all cervical malignancies, aside from gastric-type adenocarcinoma of the cervix, a rare aggressive subtype without human papillomavirus infection.  \nMethods: To address the carcinogenic mechanism of this disease, we performed a comparative multi-omics analysis of gastric-type adenocarcinoma of the cervix and usual-type endocervical adenocarcinoma in 3 independent cohorts of patients with gastric-type adenocarcinoma of the cervix and usual-type endocervical adenocarcinoma. The first cohort comprised 8 gastric-type adenocarcinoma of the cervix and 22 patients with usual-type endocervical adenocarcinoma treated at the National Cancer Center Hospital between 2002 and 2020, who were examined by targeted and whole transcriptome sequencing. The other 2 cohorts comprised 52 patients with gastric-type adenocarcinoma of the cervix and 109 patients with usual-type endocervical adenocarcinoma and 39 patients with gastric-type adenocarcinoma of the cervix and 232 patients with usual-type endocervical adenocarcinoma, whose mutational data were obtained from the Center for Cancer Genomics and Advanced Therapeutics (Japanese patients) and Genomics Evidence Neoplasia Information Exchange (US patients) public databases, respectively. Metabolomic analysis was performed in 8 patients, including 5 with gastric-type adenocarcinoma of the cervix.  \nResults: TP53 mutations were more prevalent in gastric-type adenocarcinoma of the cervix than in usual-type endocervical adenocarcinoma in all 3 cohorts. Transcriptome analysis consistently revealed frequent suppression of TP53-related pathways in gastrictype adenocarcinoma of the cervix. Metabolites preferentially detected in gastric-type adenocarcinoma of the cervix tissues suggest TP53 alterations are implicated in intratumoral metabolic properties.  \nConclusion: The development of gastric-type adenocarcinoma of the c","cbCaiuI51nPH1VOd","https://ap.wps.com/l/cbCaiuI51nPH1VOd","pdf",1803470,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Cervical cancer classification and HPV association\n## Rationale for gastric-type adenocarcinoma","[{\"question\":\"Why is TP53 a focus in gastric-type adenocarcinoma of the cervix?\",\"answer\":\"The study targets carcinogenic mechanisms in a rare HPV-independent subtype, finding TP53 mutations more common in gastric-type tumors than in usual-type endocervical adenocarcinoma.\"},{\"question\":\"How were the multi-omics datasets organized in the study?\",\"answer\":\"Comparisons were performed across three independent cohorts, combining targeted and whole transcriptome sequencing for one cohort and mutational data from public genomic databases for additional cohorts.\"},{\"question\":\"What molecular pathway and metabolite findings support the role of TP53?\",\"answer\":\"Transcriptome analysis showed frequent suppression of TP53-related pathways, and metabolite patterns in gastric-type tissues indicate TP53 alterations contribute to intratumoral metabolic properties.\"}]","TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix | PDF",1790173136,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8ab79d56e45ec3a9c82513a1593e623.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e7d58c793d224f1736ff3f235674c38.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/671a908b26797650f8e32c3c9e030aaf.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c0a1d73e974d118c9d318b9d43b96cf.webp",980,1287]